| 1.1 | Introduction by CEO | PHARMAQ in 2008 page 2 CSR 2008-2009 page 2 |
| Strategy | PHARMAQ in 2008 page 4 | |
| Governance | PHARMAQ in 2008 page 3 | |
| 1.2 | Key impacts, risks and opportunities | CSR 2008-2009 page 5 |
2. Profile - Organisational profile
| 2.1 | Name | PHARMAQ |
| 2.2 | Primary brands, products and services | PHARMAQ in 2008 page 3 |
| 2.4 | Location of headquarters | CSR 2008-2009 page 3 |
| 2.5 | Countries of operation | CSR 2008-2009 page 3 |
| 2.6 | Nature of ownership, legal form | CSR 2008-2009 page 3 |
| 2.7 | Markets served | www.pharmaq.no/About_Us/ |
| 2.8 | Scale of organisation | CSR 2008-2009 page 3 |
| 2.9 | Significant changes | Change of ownership of company .See 2.6 above. |
| 2.10 | Awards in 2008 | PHARMAQ was named as one of the top ten companies to work for in Norway under the ‘Great Place to Work’ initiative. CSR 2008-2009 page 4 |
3. Profile - Report parameters
| Report profile | ||
| 3.1 | Reporting period | 2008/09 |
| 3.2 | Previous report | 2007 |
| 3.3 | Reporting cycle | Annual to mid year |
| 3.4 | Contact point | CSR 2008-2009 page 8 |
| Report scope and boundary | Reporting of results of CSR KPIs set in 2007 and actioned in 2008/09 and establishment of KPIs for 2009/10 | |
| 3.5 | Process for defining report content | Operations controlled by PHARMAQ |
| 3.6 | Boundary of report | Those operations under the control of PHARMAQ excluding supplier and customer entities. |
| 3.7 | Limitations | This builds on the initial report and the results of the company wide survey which was completed. |
| 3.8 | Joint ventures etc. | None |
| 3.9 | Data measurement | Data is collected and verified by PHARMAQ management |
| 3.10 | Effects of restatements of information | None |
| 3.11 | Significant changes from the reporting periods in the scope, boundary or measurement methods applied | This reporting period covers an additional six months to move the cycle away from the financial reporting cycle of the company. |
| 3.12 | GRI Contents Index | This page |
| 3.13 | Assurance | None |
4. Governance, Commitment and Engagement
| Governance | ||
| 4.1–7 | Governance structure | PHARMAQ in 2008 page 3 |
| 4.8 | Internally developed statements | CSR 2008-2009 page 2 |
| 4.9–10 | Governance body’s overview | www.pharmaq.no/About_Us/ |
| Commitments to external initiatives | ||
| 4.13 | Membership in associations | Not given |
| Stakeholder engagement | ||
| 4.14–17 | Stakeholder groups engaged with | Suppliers, customers, employees and regulatory agencies. |
Economic performance indicators
| Economic performance | ||
| EC1 | Direct economic value generated and distributed | Annual Report not yet finalised for 2009 |
| EC2 | Financial implications of climate change | CSR 2008-2009 page 5 |
| EC3 | Benefit plan obligations | www.pharmaq.no/About_Us/ |
| EC4 | Financial assistance from government | None |
| Market presence | ||
| EC7 | Local recruitment | PHARMAQ companies in Norway, Chile, Vietnam and UK recruit locally |
| Indirect economic impacts | ||
| EC9 | Significant indirect economic impacts | The ISA disease situation in Chile and the general Global credit problems in 2008/09. |
Environmental Performance Indicators
| Materials | ||
| EN1 | Materials used | www.pharmaq.no/About_Us/ |
| EN2 | Percentage recycled | It is not possible to recycle veterinary products. Some peripheral materials such as packaging are recycled on a small scale. |
| Energy | ||
| EN3 | Direct energy consumption | Basic information gathered and reported by Hyder consulting Report (available in house) Data referred to throughout CSR 2008-2009 |
| EN5–7 | Energy saving | Basic information gathered and reported by Hyder consulting Report (available in house) Data referred to throughout CSR 2008-2009 |
| Water | Basic information gathered and reported by Hyder consulting Report (available in house) Data referred to throughout CSR 2008-2009 | |
| EN8–10 | Consumption of water, sources and recycling | Basic information gathered and reported by Hyder consulting Report (available in house) Data referred to throughout CSR 2008-2009 |
| Biodiversity | ||
| EN12 | Impacts of activities | Not recorded |
| EN14 | Strategies, actions, plans | None |
| EN16–27 | Emissions, Effluents and Waste | Basic information gathered and reported by Hyder consulting Report (available in house) Data referred to throughout CSR 2008-2009 |
| Compliance | ||
| EN28 | Fines and other sanctions | None |
Labour Practices and Decent Work Performance Indicators
| Employment | ||
| LA1-2 | Total workforce data | PHARMAQ in 2008 page 3 |
| Occupational Health and Safety | ||
| LA6 | Representation on site committees | Not stated |
| LA7 | Data on injuries, occupational diseases, absenteeism etc. | CSR 2008-2009 page 6 |
| Training and Education | ||
| LA10 | Average hours training per year, per employee per category | Not reported |
Human Rights Performance Indicators
| Child Labour | ||
| HR6 | Identification of risk and measures taken | Not relevant |
| Forced and Compulsory Labour | ||
| HR7 | Operations identified as having significant risk | Not relevant |
Social Performance Indicators
| Community | ||
| SO1 | Assessment of impact on communities | Not reported |
| Public Policy | ||
| S05 | Participation in public policy development and lobbying | None |
| S06 | Financial contributions to political parties, politicians and related institutions | PHARMAQ does not make such contributions |
| Anti-competitive Behaviour | ||
| SO7 | Legal actions for anti-competitive behaviour | None |
| Compliance | ||
| SO8 | Monetary value of significant fines and number of non-monetary actions for non-compliance | None |
Product Responsibility Performance Indicators
| Customer Health and Safety | ||
| PR1 | Life cycle stages in which health and safety of products and services are assessed | Raw materials, production, finished products, in the field |
GRI Application Level Grid
| 2002 in accordance | C | C+ | B | B+ | A | A+ | |
| Self decleared | V | ||||||
| Third party checked | |||||||
| GRI checked |
The assessment is made by the authors of this report.
Definitions of the application level grid can be found at (level C)